Category: NSGO-CTU


ENGOT/OV64/NSGO-CTU-SOLERO It is a great pleasure to announce, that we have executed the contract on NSGO-CTU sponsored phase II randomized trial with Apexigen. The name of the trial will be ENGOT.OV64/NSGO-CTU-SOLERO. This is great news since it is the first trial globally in ovarian cancer evaluating a CD40 agonist with or without radiation therapy in […]

New Clinical Operational Leader

NEW CLINICAL OPERATIONAL LEADER We would proudly like to announce, that Nicole Buchner Vinum, who has worked for us as Project Manager since February 2019, is now the Clinical Trial Leader of the NSGO-CTU Office, taking over from Maj Kamille Kjeldsen, who has now delegated her time to her PhD work. Now that we have […]